B, Jena Anupam; Calfee John E.; C, Mansley Edward; J, … - In: Forum for Health Economics & Policy 12 (2009) 1, pp. 1-21
Critics of me-too innovation often argue that follow-on drugs offer little incremental clinical value over existing pioneer products, while at the same time increasing health care costs. We examine whether consumers view follow-on and pioneer drugs as close substitutes or distinct clinical...